RAK-PRIDE: Optimizing Proton Pump Inhibitor Use Through Education and Intervention

Recruiting now · Not applicable

Conditions studied: Proton Pump Inhibitors, Deprescribing, Inappropriate Use

In brief

The goal of this study is to determine if a pharmacist-led educational intervention can reduce the inappropriate use of proton pump inhibitors (PPIs) among adult patients (≥18 years) with potentially inappropriate PPI prescriptions in Ras Al Khaimah. The main questions it aims to answer are: * Can a pharmacist-led education program reduce unnecessary PPI use? * Does the intervention improve patients' quality of life and reduce healthcare costs? Researchers will compare the intervention group (receiving pharmacist-led education and materials) to the usual care group to see if the intervention reduces PPI use and improves patient outcomes. Participants will: * Receive educational materials from pharmacists, including a patient educational brochure, PPI patient decision aid, PPI deprescribing pamphlet, and PPI patient action plan. * Physicians involved will also receive a pharmaceutical intervention, which includes a physician educational brochure, PPI evidence-based deprescribing guideline, PPI deprescribing algorithm, and whiteboard videos on PPI deprescribing. * Patients will be followed up for 6 months to monitor changes in PPI use, symptoms, and quality of life.

Key facts

Study ID

NCT06858384

Run by

RAK Medical and Health Sciences University

People needed

479

Starts

2025-03-01

Expected to finish

2026-02-01

Last updated by the study team

2025-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Physicians will be eligible to participate if:
• They are prescribing PPIs in outpatient department of the study sites
• They have patients with potentially inappropriate PPI prescriptions
• Patients will be eligible to participate if:
• They are ≥18 years
• They are presenting to out-patient departments of the study sites
• They have prescriptions of potentially inappropriate PPIs
• Their treating physicians are included in the study

You may not qualify if…

• Physicians will be excluded if:
• They are involved in any other prescribing trial
• Patients will be excluded if:
• They are unable to give informed consent, as judged by their physicians
• They have definitive indications for PPI use

Where it is running

• Ibrahim Bin Hamad Obaidullah Hospital — Ras al-Khaimah, United Arab Emirates (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.